(GN) GN Store Nord - CO
Sector: Healthcare | Industry: Medical Devices | Exchange: CO (Denmark) | Market Cap: 12.965m DKK | Total Return: -9.1% in 12m
Avg Turnover: 44.5M
EPS Trend: -49.0%
Qual. Beats: -1
Rev. Trend: -83.0%
Qual. Beats: 0
Warnings
Interest Coverage Ratio 0.8 is critical
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
GN Store Nord A/S is a Denmark-based technology company specializing in hearing aids and advanced audio-visual solutions. The business operates through three primary divisions: Hearing, which focuses on medical-grade instruments; Enterprise, providing professional communication hardware; and Gaming, which develops high-performance peripherals. Its portfolio includes established brands such as ReSound, Jabra, and SteelSeries.
The company operates within the hearing aid industry, which is characterized by high barriers to entry due to stringent medical regulatory requirements and significant research and development costs. By maintaining both medical and consumer electronics segments, GN Store Nord leverages a dual-track business model that captures demand from both the healthcare sector and the growing hybrid-work and professional communication markets.
- Hearing segment organic growth driven by ReSound Nexia product adoption
- Enterprise segment margins recover as professional audio inventory levels stabilize
- SteelSeries gaming revenue fluctuates with consumer discretionary spending and refresh cycles
- Deleveraging progress and free cash flow generation support balance sheet stability
| Net Income: -373.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 6.26 > 1.0 |
| NWC/Revenue: 0.26% < 20% (prev 5.64%; Δ -5.38% < -1%) |
| CFO/TA 0.11 > 3% & CFO 3.08b > Net Income -373.0m |
| Net Debt (9.23b) to EBITDA (3.23b): 2.86 < 3 |
| Current Ratio: 1.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (145.6m) vs 12m ago 0.0% < -2% |
| Gross Margin: 39.22% > 18% (prev 53.15%; Δ -13.92% > 0.5%) |
| Asset Turnover: 51.25% > 50% (prev 59.01%; Δ -7.76% > 0%) |
| Interest Coverage Ratio: 0.85 > 6 (EBIT TTM 742.0m / Interest Expense TTM 873.0m) |
| A: 0.00 (Total Current Assets 4.85b - Total Current Liabilities 4.81b) / Total Assets 28.6b |
| B: 0.47 (Retained Earnings 13.4b / Total Assets 28.6b) |
| C: 0.03 (EBIT TTM 742.0m / Avg Total Assets 29.2b) |
| D: 0.55 (Book Value of Equity 10.1b / Total Liabilities 18.4b) |
| Altman-Z'' = 2.28 = BBB |
| DSRI: 0.55 (Receivables 2.44b/5.20b, Revenue 15.0b/17.7b) |
| GMI: 1.35 (GM 53.15% / 39.22%) |
| AQI: 1.23 (AQ_t 0.82 / AQ_t-1 0.67) |
| SGI: 0.85 (Revenue 15.0b / 17.7b) |
| TATA: -0.12 (NI -373.0m - CFO 3.08b) / TA 28.6b) |
| Beneish M = -3.06 (Cap -4..+1) = AA |
As of June 20, 2026, the stock is trading at DKK 88.56 with a total of 439,875 shares traded.
Over the past week, the price has changed by -1.42%,
over one month by -7.03%,
over three months by -9.63% and
over the past year by -9.08%.
GN Store Nord has no consensus analysts rating.
P/E Trailing = 49.4667
P/E Forward = 28.7356
P/S = 0.7813
P/B = 1.2809
P/EG = 2.206
Revenue TTM = 15.0b DKK
EBIT TTM = 742.0m DKK
EBITDA TTM = 3.23b DKK
Long Term Debt = 8.03b DKK (from longTermDebt, last quarter)
Short Term Debt = 1.85b DKK (from shortTermDebt, last quarter)
Debt = 10.1b DKK (from shortLongTermDebtTotal, last quarter) + Leases 136.0m
Net Debt = 9.23b DKK (calculated: Debt 10.1b - CCE 865.0m)
Enterprise Value = 22.2b DKK (13.0b + Debt 10.1b - CCE 865.0m)
Interest Coverage Ratio = 0.85 (Ebit TTM 742.0m / Interest Expense TTM 873.0m)
EV/FCF = 8.70x (Enterprise Value 22.2b / FCF TTM 2.55b)
FCF Yield = 11.49% (FCF TTM 2.55b / Enterprise Value 22.2b)
FCF Margin = 17.02% (FCF TTM 2.55b / Revenue TTM 15.0b)
Net Margin = -2.49% (Net Income TTM -373.0m / Revenue TTM 15.0b)
Gross Margin = 39.22% ((Revenue TTM 15.0b - Cost of Revenue TTM 9.11b) / Revenue TTM)
Gross Margin QoQ = -3.16% (prev 32.94%)
Tobins Q-Ratio = 0.78 (Enterprise Value 22.2b / Total Assets 28.6b)
Interest Expense / Debt = 8.65% (Interest Expense 873.0m / Debt 10.1b)
Taxrate = 23.01% (55.0m / 239.0m)
NOPAT = 571.2m (EBIT 742.0m * (1 - 23.01%))
Current Ratio = 1.01 (Total Current Assets 4.85b / Total Current Liabilities 4.81b)
Debt / Equity = 1.00 (Debt 10.1b / totalStockholderEquity, last quarter 10.1b)
Debt / EBITDA = 2.86 (Net Debt 9.23b / EBITDA 3.23b)
Debt / FCF = 3.62 (Net Debt 9.23b / FCF TTM 2.55b)
Total Stockholder Equity = 10.5b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.28% (Net Income -373.0m / Total Assets 28.6b)
RoE = -3.55% (Net Income TTM -373.0m / Total Stockholder Equity 10.5b)
RoCE = 4.00% (EBIT 742.0m / Capital Employed (Equity 10.5b + L.T.Debt 8.03b))
RoIC = 2.30% (NOPAT 571.2m / Invested Capital 24.8b)
WACC = 7.84% (E(13.0b)/V(23.1b) * Re(8.76%) + D(10.1b)/V(23.1b) * Rd(8.65%) * (1-Tc(0.23)))
Discount Rate = 8.76% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -12.60 | Cagr: 2.09%
[DCF] Terminal Value 77.97% ; FCFF base≈1.85b ; Y1≈2.12b ; Y5≈3.12b
[DCF] Fair Price = 259.3 (EV 47.0b - Net Debt 9.23b = Equity 37.8b / Shares 145.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -48.97 | EPS CAGR: -11.69% | SUE: -2.46 | # QB: -1
Revenue Correlation: -82.95 | Revenue CAGR: -5.25% | SUE: -0.37 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.01 | Chg30d=N/A | Revisions=N/A | Analysts=1
EPS next Quarter (2026-09-30): EPS=1.12 | Chg30d=N/A | Revisions=N/A | Analysts=1
EPS current Year (2026-12-31): EPS=3.71 | Chg30d=-46.49% | Revisions=-20% | GrowthEPS=-17.2% | GrowthRev=-42.9%
EPS next Year (2027-12-31): EPS=5.44 | Chg30d=-18.99% | Revisions=-20% | GrowthEPS=+46.8% | GrowthRev=+6.0%
[Analyst] Revisions Ratio: -20%